However, identifying a low protein C or protein S level may, in some situations, impact long-term decisions about anticoagulation therapy.

但是对低水平蛋白C和S的检测，可能在某些情况下会影响对于抗凝治疗的长远决策。

Initial treatment of venous thromboembolisms is the same as it would be for patients with normal protein C and protein S levels.

对静脉血栓栓塞的初步治疗，与对拥有正常水平蛋白C和S的患者治疗是一样的。